mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.09 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.1 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |